Lv42
562 积分 2024-02-04 加入
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
3个月前
已完结
CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects
3个月前
已完结
OPTIMIZATION OF MULTIPLEX CRISPR-CAS9 EDITING OF HUMAN PRIMARY T CELLS USING LIPID NANOPARTICLES (LNPS) AND SUBSEQUENT OFF-TARGET EVALUATION
4个月前
已完结
From development to clinical success: the journey of established and next-generation BTK inhibitors
7个月前
已完结
SEED-Selection enables high-efficiency enrichment of primary T cells edited at multiple loci
8个月前
已完结
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
8个月前
已完结
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
8个月前
已完结
皖公网安备34019202002308
